FORT MYERS, FL / ACCESSWIRE / December 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading oncology testing services company, today announced that NeoGenomics Laboratories, Inc., a ...
Lab is located in same building as PPD® Laboratories’ Central Lab and will support Asia-Pacific oncology trials Fully integrated with PPD’s CRO capabilities, PPD Laboratories offers bioanalytical, ...
StockStory.org on MSN
A look back at testing & diagnostics services stocks’ Q1 earnings: NeoGenomics (NASDAQ:NEO) vs the rest of the pack
Looking back on testing & diagnostics services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today ...
-Collaboration will leverage NeoGenomics’ large oncology diagnostic laboratory and Massive Bio’s proven-at-scale proprietary artificial intelligence platform to accelerate drug discovery and optimize ...
ROLLE, SWITZERLAND--(Marketwired - November 09, 2017) - NeoGenomics Inc. (NEO), a leading global specialty oncology testing laboratory, opened the doors of its new Rolle, Switzerland facility on ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
US-based drug-development services company Covance has formed a strategic alliance with NeoGenomics, a clinical laboratory specialising in oncology-focused genetic- and molecular-testing services, for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results